Aclarion Inc/$ACON
1D1W1MYTD1Y5YMAX
Capital at risk
About Aclarion Inc
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
- Ticker
- $ACON
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 11
- Headquarters
- Broomfield, United States
- Website
- www.aclarion.com
Aclarion Inc Metrics
BasicAdvanced
$7.6M
-
-$6.22
1.22
-
Price and volume
Market cap
$7.6M
Beta
1.22
52-week high
$12.03
52-week low
$1.95
Average daily volume
59K
Financial strength
Current ratio
16.196
Quick ratio
15.742
Profitability
EBITDA (TTM)
-9.468
Gross margin (TTM)
21.76%
Net profit margin (TTM)
-10,978.48%
Operating margin (TTM)
-11,587.83%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-37.01%
Return on equity (TTM)
-58.97%
Valuation
Price to revenue (TTM)
46.632
Price to book
0.38
Price to tangible book (TTM)
0.41
Price to free cash flow (TTM)
-0.473
Free cash flow yield (TTM)
-211.48%
Free cash flow per share (TTM)
-5.583
Growth
Revenue change (TTM)
33.08%
Earnings per share change (TTM)
-48.73%
3-year revenue growth (CAGR)
0.19%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.